Breaking News Instant updates and real-time market news.

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

17:31
04/23/18
04/23
17:31
04/23/18
17:31

Epizyme down 19% after FDA hold on tazemetostat program at resumption of trade

  • 25

    Apr

EPZM Epizyme
$15.25

-0.65 (-4.09%)

02/01/18
ROTH
02/01/18
INITIATION
Target $24
ROTH
Buy
Epizyme initiated with a Buy at Roth Capital
Roth Capital analyst Jotin Marango started Epizyme with a Buy rating and $24 price target as he believes its lead agent tazemetostat, an inhibitor of the histone methyltrasferase EZH2, has laid out a sufficiently wide clinical footprint, and is sufficiently close to an NDA in several indications, that even his conservative approach of ranking its clinical programs shows that the company still remains undervalued.
02/01/18
02/01/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Epizyme (EPZM) initiated with a Buy at Roth Capital. 2. Take-Two (TTWO) initiated with an Overweight at Morgan Stanley. 3. AMERI Holdings (AMRH) initiated with an Outperform at Northland. 4. Simply Good Foods (SMPl) initiated with a Buy at SunTrust. 5. Zynerba (ZYNE) assumed with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/18
RHCO
03/14/18
NO CHANGE
Target $27
RHCO
Buy
Epizyme price target raised to $27 from $21 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Epizyme to $27, saying the company's Q4 earnings call reiterated expectations of on-track data flow in epithelioid sarcoma registrations / NDA filing later this year, the combo data for DLBCL, and the follicular lymphoma data and registration path in the second half of 2018. Lawson keeps his Buy rating and attributes his price target revision to the treatment's higher probability of success.
04/11/18
JEFF
04/11/18
NO CHANGE
Target $27
JEFF
Buy
Epizyme recent pullback creates attractive risk/reward, says Jefferies
Jefferies analyst Michael Yee believes the recent pullback in shares of Epizyme creates an attractive risk/reward ahead of a "catalyst-rich" 2018. The company's market capitalization could appreciate from less than $1B to $2-$3B over time if data in the second half "starts to play out like we expect," Yee tells investors in a research note. He thinks Epizyme's mixed shelf filing last week has some investors concerned that an equity financing could be possible in the near term. Yee believes, however, that the filing "simply replaces and refreshes" an existing one that has always been on hand as opposed to suggesting the company is getting ready to raise near-term cash. The analyst keeps a Buy rating on the shares with a $27 price target.

TODAY'S FREE FLY STORIES

GRMN

Garmin

$64.96

(0.00%)

, ASNA

Ascena Retail

$2.73

(0.00%)

09:40
12/11/18
12/11
09:40
12/11/18
09:40
Options
Unusually active option classes on open December 11th »

Unusual total active…

GRMN

Garmin

$64.96

(0.00%)

ASNA

Ascena Retail

$2.73

(0.00%)

KBE

KBW Bank ETF

$40.27

(0.00%)

CMCSA

Comcast

$37.36

(0.00%)

XME

SPDR S&P Metals & Mining

$27.72

(0.00%)

FCX

Freeport McMoRan

$10.69

(0.00%)

OIH

Oil Services Holders Trust

$16.46

(0.00%)

VZ

Verizon

$58.27

(0.00%)

JPM

JPMorgan

$101.34

(0.00%)

T

AT&T

$29.91

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 13

    Dec

  • 30

    Jan

  • 26

    Feb

  • 20

    Mar

IGXT

IntelGenx

$0.00

(0.00%)

09:39
12/11/18
12/11
09:39
12/11/18
09:39
Conference/Events
IntelGenx management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 01

    Apr

AAPL

Apple

$169.61

1.24 (0.74%)

09:39
12/11/18
12/11
09:39
12/11/18
09:39
Recommendations
Apple analyst commentary  »

Apple Taiwanese…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$34.80

-0.51 (-1.44%)

, INTC

Intel

$47.21

0.98 (2.12%)

09:36
12/11/18
12/11
09:36
12/11/18
09:36
Recommendations
Micron, Intel, Western Digital, Nvidia, AMD analyst commentary  »

Goldman Sachs lowers…

MU

Micron

$34.80

-0.51 (-1.44%)

INTC

Intel

$47.21

0.98 (2.12%)

WDC

Western Digital

$41.67

-0.395 (-0.94%)

NVDA

Nvidia

$151.98

4.44 (3.01%)

AMD

AMD

$19.98

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

  • 06

    Jan

CZZ

Cosan

$8.37

-0.14 (-1.65%)

09:35
12/11/18
12/11
09:35
12/11/18
09:35
Downgrade
Cosan rating change  »

Cosan downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$19.98

0.53 (2.72%)

09:34
12/11/18
12/11
09:34
12/11/18
09:34
Technical Analysis
Technical Take: AMD outperforms, analyst action »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITUB

Itau Unibanco

$8.80

-0.275 (-3.03%)

09:34
12/11/18
12/11
09:34
12/11/18
09:34
Downgrade
Itau Unibanco rating change  »

Itau Unibanco downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSBR

Santander Brasil

$10.87

-0.3 (-2.69%)

09:34
12/11/18
12/11
09:34
12/11/18
09:34
Downgrade
Santander Brasil rating change  »

Santander Brasil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBD

Banco Bradesco

$9.43

-0.23 (-2.38%)

09:32
12/11/18
12/11
09:32
12/11/18
09:32
Downgrade
Banco Bradesco rating change  »

Banco Bradesco downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$169.61

1.24 (0.74%)

, GOOG

Alphabet

$1,040.02

3.5 (0.34%)

09:29
12/11/18
12/11
09:29
12/11/18
09:29
Periodicals
Apple launches mobile payments service in Germany, Reuters reports »

Apple (AAPL) launched its…

AAPL

Apple

$169.61

1.24 (0.74%)

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

TBPH

Theravance Biopharma

$27.00

0.18 (0.67%)

09:28
12/11/18
12/11
09:28
12/11/18
09:28
Conference/Events
Theravance Biopharma to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ZEN

Zendesk

$58.62

0.21 (0.36%)

09:27
12/11/18
12/11
09:27
12/11/18
09:27
Conference/Events
Zendesk management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 19

    Dec

  • 20

    Dec

KAR

KAR Auction

$50.43

-0.61 (-1.20%)

09:26
12/11/18
12/11
09:26
12/11/18
09:26
Conference/Events
KAR Auction management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

AXP

American Express

$105.82

-0.905 (-0.85%)

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
American Express management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

CVS

CVS Health

$73.34

-0.75 (-1.01%)

, AET

Aetna

$0.00

(0.00%)

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Recommendations
CVS Health, Aetna, Amazon.com analyst commentary  »

CVS Health assumed with…

CVS

CVS Health

$73.34

-0.75 (-1.01%)

AET

Aetna

$0.00

(0.00%)

AMZN

Amazon.com

$1,640.37

11.18 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

STNG

Scorpio Tankers

$2.05

(0.00%)

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
Scorpio Tankers to host an analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
JPMorgan pharmaceuticals analyst to hold analyst/industry conference call »

Pharmaceuticals Analyst…

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
JPMorgan oilfield service/equip analyst to hold analyst/industry conference call »

Oilfield…

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
UBS Spanish/Italian banking analyst to hold analyst/industry conference call »

Spanish/Italian Banking…

ZION

Zions Bancorp

$44.25

-0.86 (-1.91%)

09:24
12/11/18
12/11
09:24
12/11/18
09:24
Conference/Events
Zions Bancorp management to meet with Sandler O'Neill »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NKE

Nike

$72.50

-0.86 (-1.17%)

09:24
12/11/18
12/11
09:24
12/11/18
09:24
Recommendations
Nike analyst commentary  »

Nike shares at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

DX

Dynex Capital

$5.95

-0.06 (-1.00%)

09:23
12/11/18
12/11
09:23
12/11/18
09:23
Hot Stocks
Dynex Capital to pay common dividend distributions monthly starting in 2019 »

Dynex Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$365.20

7.355 (2.06%)

09:23
12/11/18
12/11
09:23
12/11/18
09:23
Hot Stocks
Tesla's Musk says tax credit in U.S. going down $3,750 in three weeks »

Tesla CEO Elon Musk says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SMCI

Super Micro Computer

$0.00

(0.00%)

, AAPL

Apple

$169.61

1.24 (0.74%)

09:23
12/11/18
12/11
09:23
12/11/18
09:23
Periodicals
Super Micro: Probe found no malicious chips in motherboards, Reuters reports »

Super Micro Computer…

SMCI

Super Micro Computer

$0.00

(0.00%)

AAPL

Apple

$169.61

1.24 (0.74%)

AMZN

Amazon.com

$1,640.37

11.18 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 19

    Dec

  • 20

    Dec

PTR

PetroChina

$67.72

-0.84 (-1.23%)

09:22
12/11/18
12/11
09:22
12/11/18
09:22
Downgrade
PetroChina rating change  »

PetroChina downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.